Comparing Two Ways to Manage Head and Neck Lymphedema

Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors

This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.

Primary aim: To compare the effects of clinic-based and home-based (a hybrid model) CDT on changes in the severity of lymphedema.

Secondary aim: To compare the effects of clinic-based and home-based (a hybrid model) CDT on symptom burden and functional status.

Exploratory aim: To compare the healthcare utilization between patients receiving clinic-based versus home-based (a hybrid model) CDT

Inclusion Criteria:

• >18 years of age
• <=24 months post-HNC treatment
• Diagnosis of head and neck lymphedema and referral by their oncology providers
• Able to perform self-manual lymphatic drainage
• Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home

Exclusion Criteria:

• Active infection in soft tissues in the head and neck region
• History of moderate or severe carotid artery occlusion
• Significantly severe lymphedema (e.g., severe periorbital swelling)
• Conditions impacting the safe delivery of lymphedema therapy